Interclean Shanghai

Emids unveils Generative AI platform EPulseAI for healthcare industry

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Emids, a transformation and digital engineering solution for the healthcare and life sciences industry has launched its Generative AI platform, ‘EPulseAI’ by Emids for the healthcare industry.

The platform is targeted at all participants in the healthcare ecosystem in the US—payers, providers, and tech companies, enabling them to drive better outcomes for patients. EPulseAI accelerates product engineering and enhances productivity across the entire product development lifecycle by as much as 50 per cent

The implications of Generative AI in healthcare are truly remarkable. AI is redefining the way we process healthcare data to diagnose diseases, develop treatments and even prevent them altogether. We are thrilled to launch EPulseAI by Emids at a time when the healthcare industry is poised for this digital transformation journey with AI at its core. It is a purpose-built solution that empowers healthcare enterprises to accelerate and expand their Generative AI capabilities,” said Sean Narayanan, Chief Executive Officer at Emids.

Developed in-house, this Generative AI platform kicks off AI centers of excellence in Bangalore and Tennessee for Emids. The platform assists clients in streamlining activities from product ideation to rollout. The integration of EPulseAI into the product development process will enable better products that can improve the quality of medical care, enhance patient outcomes, and elevate customer experience, said the company.

Previously time-consuming tasks that would require several hours of manual effort can now be accomplished in just a few minutes through the new user interface based on Generative AI, resulting in an impressive user experience with human-like interaction. This streamlined approach not only saves time and resources but also paves the way for remarkable advancements in healthcare operations, ultimately benefitting all stakeholders involved.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »